Back to Grants
FEDERAL
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
This grant funds research to address methodological challenges in clinical trials of rapid-acting psychotropic interventional drugs.
About this program
The grant focuses on improving the design and implementation of clinical trials for rapid-acting psychotropic drugs, which are crucial for treating mental health conditions. It aims to support researchers in developing innovative methodologies that can enhance the efficacy and reliability of these trials. This funding is intended for academic institutions, research organizations, and other entities engaged in mental health research.
Eligibility
Eligible applicants include academic institutions, research organizations, and other entities involved in clinical research.
Requirements
- Must conduct clinical trials
- Must focus on rapid-acting psychotropic drugs